FDA approves Merck's Keytruda for FIGO 2014 cervical cancer

Stock Information for Harpoon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Harpoon Therapeutics Inc.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TGAN
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, TARO, FFNW
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - HARP, FGH, BBAI
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, JNPR, TGAN, TAST
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BBAI, HARP, FGH, PGTI
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TARO
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - MDC, HARP, CVLY, AXNX
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates HARP, JNPR, TGAN

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.